Lewis B. Silverman - Concepedia

Author

Lewis B. Silverman

Also Known As

Brain, Joseph D., L B Silverman, L SILVERMAN, L Silverman, L. B. Silverman, L. Silverman, L.B. Silverman, Lewis B Silverman, Lewis B. Silverman, Lewis Silverman

487

Publications

28.1K

Citations

H-Index

137

Concepts

All Affiliations

Dana-Farber Cancer Institute Boston Children's Hospital Harvard University Centre Hospitalier Universitaire Sainte-Justine Université de Montréal

About

Lewis B. Silverman is an author at Dana-Farber Cancer Institute specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	43	11.2K
2	Health Sciences	6	6	405
3	Engineering	2	2	1.1K
4	Arts	1	1	14
5	Education	1	1	49

Lewis B. Silverman

177

Publications

25K

Citations

H-Index

Page 1

	Year	Citations
Activating Mutations of <i>NOTCH1</i> in Human T Cell Acute Lymphoblastic Leukemia Andrew P. Weng, Adolfo A. Ferrando, Woojoong Lee, Science Hematological MalignancyHuman T-allActivated Notch1Lymphocyte DevelopmentHuman T Cell	2004	2.7K
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Scott A. Armstrong, Jane Staunton, Lewis B. Silverman, Nature Genetics Hematological MalignancyChromatinDistinct Gene ExpressionMixed-phenotype Acute LeukemiaGenetics	2001	1.7K
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Marc R. Mansour, Brian J. Abraham, Lars Anders, Science EngineeringMixed-phenotype Acute LeukemiaGeneticsMolecular BiologyEpigenetics	2014	797
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial Rob Pieters, Martin Schrappe, Paola De Lorenzo, The Lancet Hematological MalignancyAcute Lymphoblastic LeukaemiaOncologyPediatric EpidemiologyPediatric Hematology	2007	644
The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia Steven E. Lipshultz, Nader Rifai, Virginia Dalton, New England Journal of Medicine	2004	619
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Maurizio Aricò, Maria Grazia Valsecchi, Bruce M. Camitta, New England Journal of Medicine	2000	591
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy Tríona Ní Chonghaile, Kristopher A. Sarosiek, Thanh-Trang T. Vo, Science ApoptosisCell DeathPathologyTumor BiologyCytotoxic Chemotherapy Targets	2011	578
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias Andrei V. Krivtsov, Zhaohui Feng, Madeleine E. Lemieux, Cancer Cell ChromatinEpigenetic ChangeDna MethylationEpigenomicsMedicine	2008	547
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz, The Lancet Oncology Drug SafetyHematological MalignancyOncologyDoxorubicin-treated ChildrenPediatric Hematology	2010	442
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia Alejandro Gutiérrez, Takaomi Sanda, Ruta Grebliunaite, Blood	2009	436

Page 1